4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerase chain reaction
- 1 February 1991
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (2) , 387-389
- https://doi.org/10.1128/aac.35.2.387
Abstract
Seven nalidixic acid-resistant clinical isolates of Escherichia coli were shown to carry resistance mutations in their gyrase A proteins. Six had serine-83 to leucine or tryptophan changes; the seventh had an aspartate-87 to valine substitution. The frequent occurrence of a mutation at serine-83 implies a key role for this residue in quinolone action.Keywords
This publication has 20 references indexed in Scilit:
- Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coliAntimicrobial Agents and Chemotherapy, 1990
- Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolonesAntimicrobial Agents and Chemotherapy, 1989
- Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding modelBiochemistry, 1989
- gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coliAntimicrobial Agents and Chemotherapy, 1989
- Quinolone-resistant mutations of the gyrA gene of Escherichia coliMolecular Genetics and Genomics, 1988
- Cloning and sequencing of the Escherichia coli gyrA gene coding for the a subunit of DNA gyraseJournal of Molecular Biology, 1987
- Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coliMolecular Genetics and Genomics, 1986
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985
- Nalidixic acid resistance: A second genetic character involved in DNA gyrase activityProceedings of the National Academy of Sciences, 1977